Galectin-9 in physiological and pathological conditions

被引:163
|
作者
Hirashima, M
Kashio, Y
Nishi, N
Yamauchi, A
Imaizumi, T
Kageshita, T
Saita, N
Nakamura, T
机构
[1] Kagawa Med Univ, Dept Immunol & Immunopathol, Miki, Kagawa 7610793, Japan
[2] Kagawa Med Univ, Dept Endocrinol, Miki, Kagawa 7610793, Japan
[3] Kagawa Med Univ, Dept Surg, Miki, Kagawa 7610793, Japan
[4] Hirosaki Univ, Sch Med, Inst brain Sci, Dept Vasc Biol, Hirosaki, Aomori 036, Japan
[5] Kumamoto Univ, Sch Med, Dept Dermatol, Kumamoto 860, Japan
[6] Kumamoto Univ, Sch Med, Dept Internal Med, Kumamoto 860, Japan
关键词
galectin-9 (Gal-9); eosinophil activation; cancer; apoptosis; prognosis;
D O I
10.1023/B:GLYC.0000014090.63206.2f
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We first cloned galectin-9 (Gal-9)/ecalectin as a T cell-derived eosinophil chemoattractant. Gal-9 plays a role in not only accumulation but also activation of eosinophils in experimental allergic models and human allergic patients, because Gal-9 induces eosinophil chemoattraction in vitro and in vivo and activates eosinophils in many aspects. Gal-9 requires divalent galactoside-binding activity but not the linker peptide of Gal-9 to exhibit its biological functions, and an unidentified matrix metalloproteinase is involved in the release of Gal-9. Our recent studies also showed that Gal-9 has other functions, such as cell differentiation, aggregation, adhesion, and death. Now, we and other groups are on the way of investigating the regulation and function of Gal-9 in a variety of physiological and pathological conditions. In this article, we will show the possible role of Gal-9 in physiological and pathological conditions by using our recent findings.
引用
收藏
页码:593 / 600
页数:8
相关论文
共 50 条
  • [31] The regulating role of galectin-9 in immune cell populations
    Cao, Zhanqi
    Leng, Ping
    Xu, Hanlin
    Li, Xiangpeng
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [32] Reduced expression of galectin-1 and galectin-9 by leucocytes in asthma patients
    Sanchez-Cuellar, S.
    de la Fuente, H.
    Cruz-Adalia, A.
    Lamana, A.
    Cibrian, D.
    Giron, R. M.
    Vara, A.
    Sanchez-Madrid, F.
    Ancochea, J.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2012, 170 (03): : 365 - 374
  • [33] Galectin-9 is a target for the treatment of cancer: A patent review
    Rodrigues, Cassia Ferreira
    Santos, Francisco Alves
    Amorim, Leonardo Andrade Abreu
    da Silva, Andre Luis Coelho
    Marques, Lana Grasiela Alves
    Rocha, Bruno Anderson Matias
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 254
  • [34] Alarmin Function of Galectin-9 in Murine Respiratory Tularemia
    Steichen, Anthony L.
    Simonson, Tanner J.
    Salmon, Sharon L.
    Metzger, Dennis W.
    Mishra, Bibhuti B.
    Sharma, Jyotika
    PLOS ONE, 2015, 10 (04):
  • [35] Different angioregulatory activity of monovalent galectin-9 isoforms
    Ed Aanhane
    Iris A. Schulkens
    Roy Heusschen
    Kitty Castricum
    Hakon Leffler
    Arjan W. Griffioen
    Victor L. Thijssen
    Angiogenesis, 2018, 21 : 545 - 555
  • [36] Role of downregulation of galectin-9 in the tumorigenesis of gastric cancer
    Yang, Jiaxing
    Zhu, Lin
    Cai, Yong
    Suo, Jian
    Jin, Jingji
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (03) : 1313 - 1320
  • [37] A unique role for galectin-9 in angiogenesis and inflammatory arthritis
    O'Brien, Martin J.
    Shu, Qiang
    Stinson, W. Alexander
    Tsou, Pei-Suen
    Ruth, Jeffrey H.
    Isozaki, Takeo
    Campbell, Phillip L.
    Ohara, Ray A.
    Koch, Alisa E.
    Fox, David A.
    Amin, M. Asif
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [38] Alarmin function of galectin-9 in murine respiratory tularemia
    Sharma, Jyotika
    Steichen, Anthony
    Simonson, Tanner
    Salmon, Sharon
    Metzger, Dennis
    Mishra, Bibhuti
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [39] T Cells Are Smad'ly in Love with Galectin-9
    Cummings, Richard D.
    IMMUNITY, 2014, 41 (02) : 171 - 173
  • [40] A unique role for galectin-9 in angiogenesis and inflammatory arthritis
    Martin J. O’Brien
    Qiang Shu
    W.Alexander Stinson
    Pei-Suen Tsou
    Jeffrey H. Ruth
    Takeo Isozaki
    Phillip L. Campbell
    Ray A. Ohara
    Alisa E. Koch
    David A. Fox
    M. Asif Amin
    Arthritis Research & Therapy, 20